skip to main content
Idioma:
Refinado por: Nome da Publicação: Investigational New Drugs remover Science Citation Index Expanded (Web of Science) remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors
A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase Ib open-label dose escalation study of the safety, pharmacokinetics, and pharmacodynamics of cobimetinib (GDC-0973) and ipatasertib (GDC-0068) in patients with locally advanced or metastatic solid tumors

Shapiro, Geoffrey I. ; LoRusso, Patricia ; Cho, Daniel C. ; Musib, Luna ; Yan, Yibing ; Wongchenko, Matthew ; Chang, Ilsung ; Patel, Premal ; Chan, Iris T. ; Sanabria-Bohorquez, Sandra ; Meng, Raymond D. ; Bendell, Johanna C.

Investigational new drugs, 2021-02, Vol.39 (1), p.163-174 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
2
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors

Jones, Suzanne F. ; Siu, Lillian L. ; Bendell, Johanna C. ; Cleary, James M. ; Razak, Albiruni R. A. ; Infante, Jeffrey R. ; Pandya, Shuchi S. ; Bedard, Philippe L. ; Pierce, Kristen J. ; Houk, Brett ; Roberts, W. Gregory ; Shreeve, S. Martin ; Shapiro, Geoffrey I.

Investigational new drugs, 2015-10, Vol.33 (5), p.1100-1107 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
3
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors
Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Phase I dose-escalation and -expansion study of buparlisib (BKM120), an oral pan-Class I PI3K inhibitor, in patients with advanced solid tumors

Rodon, Jordi ; Braña, Irene ; Siu, Lillian L ; De Jonge, Maja J ; Homji, Natasha ; Mills, David ; Di Tomaso, Emmanuelle ; Sarr, Celine ; Trandafir, Lucia ; Massacesi, Cristian ; Eskens, Ferry ; Bendell, Johanna C

Investigational new drugs, 2014-08, Vol.32 (4), p.670-681 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
4
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors
Material Type:
Artigo 		Adicionar ao Meu Espaço

A phase 1 study of the sachet formulation of the oral dual PI3K/mTOR inhibitor BEZ235 given twice daily (BID) in patients with advanced solid tumors

Bendell, Johanna C. ; Kurkjian, Carla ; Infante, Jeffrey R. ; Bauer, Todd M. ; Burris, Howard A. ; Greco, F. Anthony ; Shih, Kent C. ; Thompson, Dana S. ; Lane, Cassie M. ; Finney, Lindsey H. ; Jones, Suzanne F.

Investigational new drugs, 2015-04, Vol.33 (2), p.463-471 [Periódico revisado por pares]

Boston: Springer US

Texto completo disponível

Citações Citado por

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Assunto 

  1. Cancer Therapies  (3)
  2. Adult  (3)
  3. Mais opções open sub menu

Data de Publicação 

De até
Refinar

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.